ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer
ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer
Anal cancer is a rare disease, but the incidence is rising. About 200 patients will get this
 type of cancer yearly in Sweden. Curative treatment includes chemotherapy and radiotherapy.
 The prognosis is good, but some patients will have recurrent or persistent disease after
 concluded chemo-radiotherapy and will then be offered salvage surgery. Some patients develop
 distant metastases that can be treated with good results.

 The aim of this study is to identify and describe functional outcome in patients diagnosed
 with anal cancer. We will study patients from diagnosis, try to identify early toxicity to
 treatment and then identify long-term morbidity.
Inclusion Criteria:

 -  Age > 18 years

 -  Anal squamous carcinoma diagnosed within the last 2 months

 Exclusion Criteria:

 -No informed consent